These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 2551973)
1. Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases. Katz BZ; Raab-Traub N; Miller G J Infect Dis; 1989 Oct; 160(4):589-98. PubMed ID: 2551973 [TBL] [Abstract][Full Text] [Related]
2. Use of cloned probes to detect Epstein-Barr viral DNA in tissues of patients with neoplastic and lymphoproliferative diseases. Andiman W; Gradoville L; Heston L; Neydorff R; Savage ME; Kitchingman G; Shedd D; Miller G J Infect Dis; 1983 Dec; 148(6):967-77. PubMed ID: 6317774 [TBL] [Abstract][Full Text] [Related]
4. Documentation of Epstein-Barr virus infection in immunodeficient patients with life-threatening lymphoproliferative diseases by Epstein-Barr virus complementary RNA/DNA and viral DNA/DNA hybridization. Saemundsen AK; Purtilo DT; Sakamoto K; Sullivan JL; Synnerholm AC; Hanto D; Simmons R; Anvret M; Collins R; Klein G Cancer Res; 1981 Nov; 41(11 Pt 1):4237-42. PubMed ID: 6272968 [TBL] [Abstract][Full Text] [Related]
5. In situ hybridization for Epstein-Barr virus NotI repeats in posttransplant lymphoproliferative disorder. Montone KT; Friedman H; Hodinka RL; Hicks DG; Kant JA; Tomaszewski JE Mod Pathol; 1992 May; 5(3):292-302. PubMed ID: 1323104 [TBL] [Abstract][Full Text] [Related]
6. Presence of the diffuse early antigen of Epstein-Barr virus in lymphomas and lymphoproliferative disorders. Katz BZ; Saini U Am J Pathol; 1992 May; 140(5):1247-54. PubMed ID: 1316087 [TBL] [Abstract][Full Text] [Related]
7. Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation. Rea D; Fourcade C; Leblond V; Rowe M; Joab I; Edelman L; Bitker MO; Gandjbakhch I; Suberbielle C; Farcet JP Transplantation; 1994 Aug; 58(3):317-24. PubMed ID: 8053055 [TBL] [Abstract][Full Text] [Related]
8. Comparison of polymerase chain reaction and standard Southern blotting for the detection of Epstein-Barr virus DNA in various biopsy specimens. Pedneault L; Katz BZ J Med Virol; 1993 Jan; 39(1):33-43. PubMed ID: 8380841 [TBL] [Abstract][Full Text] [Related]
9. The impact of EBV hybridization in clinical and biological medicine. Morinet F Nouv Rev Fr Hematol (1978); 1989; 31(2):155-8. PubMed ID: 2549502 [TBL] [Abstract][Full Text] [Related]
10. Replicative viral DNA in Epstein-Barr virus associated Burkitt's lymphoma biopsies. Gutierrez MI; Bhatia K; Magrath I Leuk Res; 1993 Mar; 17(3):285-9. PubMed ID: 8383779 [TBL] [Abstract][Full Text] [Related]
11. Clonal analysis of posttransplant lymphoproliferative disorders, using both episomal Epstein-Barr virus and immunoglobulin genes as markers. Kaplan MA; Ferry JA; Harris NL; Jacobson JO Am J Clin Pathol; 1994 May; 101(5):590-6. PubMed ID: 8178765 [TBL] [Abstract][Full Text] [Related]
12. Presence of Epstein-Barr virus latency type III at the single cell level in post-transplantation lymphoproliferative disorders and AIDS related lymphomas. Brink AA; Dukers DF; van den Brule AJ; Oudejans JJ; Middeldorp JM; Meijer CJ; Jiwa M J Clin Pathol; 1997 Nov; 50(11):911-8. PubMed ID: 9462239 [TBL] [Abstract][Full Text] [Related]
13. Epstein-Barr virus detection in non-Hodgkin's lymphoma of the oral cavity: an immunocytochemical and in situ hybridization study. Leong IT; Fernandes BJ; Mock D Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Aug; 92(2):184-93. PubMed ID: 11505266 [TBL] [Abstract][Full Text] [Related]
14. Differential cellular susceptibility to Epstein-Barr virus infection in a patient with X-linked lymphoproliferative disease. Okano M; Thiele GM; Gross TG; Davis JR; Purtilo DT J Med Virol; 1990 Sep; 32(1):47-52. PubMed ID: 2173737 [TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus infections and DNA hybridization studies in posttransplantation lymphoma and lymphoproliferative lesions: the role of primary infection. Ho M; Miller G; Atchison RW; Breinig MK; Dummer JS; Andiman W; Starzl TE; Eastman R; Griffith BP; Hardesty RL J Infect Dis; 1985 Nov; 152(5):876-86. PubMed ID: 2995512 [TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr-virus-associated lymphoproliferative syndrome in severe combined immunodeficiency: establishment of a lymphoblastoid cell line as an in vitro model for biological and therapeutic studies. Simon M; Borisch B; Heymer B Acta Haematol; 1996; 96(3):170-7. PubMed ID: 8876615 [TBL] [Abstract][Full Text] [Related]
17. Demonstration of Epstein-Barr viral DNA in paraffin-embedded specimens of lymphoproliferative syndrome. Evidence for a productive infection comparable to lymphoblastoid cell lines. Simon M; Neumann R; Bültmann B Pathol Res Pract; 1992 Feb; 188(1-2):106-14. PubMed ID: 1317554 [TBL] [Abstract][Full Text] [Related]
18. Biomolecular analysis of a defective nontransforming Epstein-Barr virus (EBV) from a patient with chronic active EBV infection. Alfieri C; Joncas JH J Virol; 1987 Oct; 61(10):3306-9. PubMed ID: 3041050 [TBL] [Abstract][Full Text] [Related]
19. Synchronous and sequential activation of latently infected Epstein-Barr virus genomes. Takada K; Ono Y J Virol; 1989 Jan; 63(1):445-9. PubMed ID: 2462063 [TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus integration in human lymphomas and lymphoid cell lines. Gulley ML; Raphael M; Lutz CT; Ross DW; Raab-Traub N Cancer; 1992 Jul; 70(1):185-91. PubMed ID: 1318776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]